Emc Capital Management Simulations Plus, Inc. Transaction History

Emc Capital Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$40.55 - $51.76 $98,374 - $125,569	-2,426 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$36.56 - $50.98 $575,856 - $802,985	-15,751 Reduced 86.65%	2,426 $113,000
Q4 2021 Feb 10, 2022	BUY	$37.1 - $57.45 $102,358 - $158,504	2,759 Added 17.89%	18,177 $860,000
Q3 2021 Nov 02, 2021	BUY	$38.45 - $55.66 $78,937 - $114,269	2,053 Added 15.36%	15,418 $779,000
Q2 2021 Aug 09, 2021	BUY	$49.67 - $68.96 $66,110 - $91,785	1,331 Added 11.06%	13,365 $734,000
Q1 2021 May 05, 2021	BUY	$60.06 - $89.52 $62,882 - $93,727	1,047 Added 9.53%	12,034 $761,000
Q4 2020 Feb 24, 2021	BUY	$53.26 - $77.18 $585,167 - $847,976	10,987 New	10,987 $790,000

176

15.2M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $636M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Emc Capital Management, based on Form 13F filings with the SEC.

Stay updated on Emc Capital Management with notifications on news.